Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

Theravance Biopharma Inc. (TBPH : NSD)

Sector: Healthcare

Close
(03-03-2026)
$13.96
Change
-$4.99 (-26.33%)
Volume 4,387,963
Open $14.27
Day Range $13.08 - $14.90
52 Week Low $7.90
52 Week High $21.03
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $707,387,137
Shares Outstanding 50,672,431
Book Value per Share $3.04
Earnings per Share $0.57
Period
Loading...
Loading...

Legend

Theravance Biopharma Inc.

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
March 03, 2026 13.96
-$4.99 (-26.33%)
March 02, 2026 18.95
$0.70 (3.84%)
February 27, 2026 18.25
$0.06 (0.33%)
February 26, 2026 18.19
-$0.87 (-4.56%)
February 25, 2026 19.06
$0.00 (0.00%)
February 24, 2026 19.06
-$0.20 (-1.04%)
February 23, 2026 19.26
-$0.40 (-2.03%)
February 20, 2026 19.66
$0.23 (1.18%)
February 19, 2026 19.43
$0.26 (1.36%)
February 18, 2026 19.17
$0.36 (1.91%)
February 17, 2026 18.81
-$0.72 (-3.69%)
February 16, 2026 19.53
$0.00 (0.00%)
February 13, 2026 19.53
$0.13 (0.67%)
February 12, 2026 19.40
-$0.11 (-0.56%)
February 11, 2026 19.51
$0.11 (0.57%)
February 10, 2026 19.40
-$0.10 (-0.51%)
February 09, 2026 19.50
-$0.98 (-4.79%)
February 06, 2026 20.48
$0.90 (4.60%)
February 05, 2026 19.58
-$0.51 (-2.54%)
February 04, 2026 20.09
$0.10 (0.50%)
February 03, 2026 19.99
$0.16 (0.81%)
February 02, 2026 19.83
$0.89 (4.70%)
January 30, 2026 18.94
-$0.24 (-1.25%)
January 29, 2026 19.18
$0.15 (0.79%)
January 28, 2026 19.03
-$0.79 (-3.99%)
January 27, 2026 19.82
$0.07 (0.35%)
January 26, 2026 19.75
-$0.49 (-2.42%)
January 23, 2026 20.24
-$0.50 (-2.41%)
January 22, 2026 20.74
$0.37 (1.82%)
January 21, 2026 20.37
-$0.05 (-0.24%)

Funds holding this stock

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports